Steven Bleyl

Dr. Steven Bleyl is a prominent figure in the field of medical genetics, currently serving as the Chief Medical Officer (CMO) at Genome Medical, a digital health company focused on integrating genetics and genomics into everyday healthcare. He has held this position since January 2017, where he has been instrumental in developing clinical care processes aimed at enhancing patient access to genomic medicine.14

Education and Background

Dr. Bleyl holds an M.D. and a Ph.D. in human genetics from the University of Utah, where he also completed his fellowship in medical genetics. His academic pursuits include a focus on cardiovascular genetics, particularly congenital heart defects, which affect approximately 1 in 100 live births.23 He has directed significant research initiatives, including studies on congenital defects of the pulmonary veins, identifying genetic risk factors through next-generation sequencing techniques.3

Professional Experience

Before joining Genome Medical, Dr. Bleyl led the Clinical Genetics Institute for Intermountain Healthcare. In this role, he oversaw the provision of genetic services and implemented innovative programs such as rapid exome sequencing for neonates and a Genetic Testing Stewardship Program.25 His clinical practice is complemented by his academic role as an adjunct Associate Professor at the University of Utah, where he teaches embryology and actively engages in research related to genetic conditions.13

Contributions to Genomic Medicine

At Genome Medical, Dr. Bleyl has been pivotal in expanding the company's technology infrastructure to enhance virtual genomic care delivery. This includes the integration of tools for comprehensive family health history collection and genomic decision support systems aimed at improving patient care efficiency.4 His leadership is characterized by a commitment to making genomic insights more accessible and actionable for both clinicians and patients.

Research Interests

Dr. Bleyl's research focuses on identifying genetic risk factors for congenital heart defects and other birth defects using genetic mapping techniques within extended families. His work has contributed significantly to understanding the genetic underpinnings of these conditions, which have profound impacts on affected individuals and their families.34

In summary, Dr. Steven Bleyl is a distinguished medical geneticist whose expertise spans clinical practice, academic research, and leadership in genomic healthcare innovation. His contributions continue to shape the landscape of precision medicine and improve patient outcomes through enhanced access to genetic services.